LONDONA flurry of new cancerdrug data coming from a conference in Europe is offering fresh promise for immunotherapiesdrugs that boost patients immune systemsespecially their prospects when combined with other immunotherapies and existing drugs  A highlight from the closely watched conference which kicked off in Madrid Friday has been the encouraging trial results for immunotherapy drugs that release one specific brake on the immune systemacting on a protein called Programmed Death Receptor  PD or a related target
  